Dapivirine Vaginal Ring for PrEP Does Not Lead to Drug Resistance
MTN research presented at R4P 2018 found that use of the dapivirine vaginal ring did not lead to resistance mutations in women participating in ASPIRE who seroconverted.
The Body PRO
MTN research presented at R4P 2018 found that use of the dapivirine vaginal ring did not lead to resistance mutations in women participating in ASPIRE who seroconverted.